ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 854,99
-0,92%
Dow Jones
44 424,25
-0,32%
DAX
21 154,53
-1,08%
Brent Oil
77,495
0,40%
Bitcoin
98 969,11
-5,44%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Sunshine Biopharma Inc (SBFM) Cours

Sunshine Biopharma Inc

Sunshine Biopharma Inc (SBFM)

NASDAQ
2,87
-0,02
(-0,69%)
Fermé 25 Janvier 10:00PM
Retardé de 15 minutes
2,87
0,00
( 0,00% )
Avant marché: 10:01AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
2,87
Prix Achat
2,80
Prix Vente
2,92
Volume échangé
-
0,00 Fourchette du Jour 0,00
2,1056 Plage de 52 semaines 571,20
Cap du marché
5,739M
Clôture Veille
2,87
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
769 737
Actions en circulation
1 999 660
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,27
Bénéfice par action (BPA)
-2,25
Chiffre d'affairess
24,09M
Bénéfice net
-4,51M

À propos de Sunshine Biopharma Inc

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Show more

Secteur
Coml Physical, Biologcl Resh
Industrie
Coml Physical, Biologcl Resh
Site Web
www.sunshinebiopharma.com
Siège social
Montreal, Quebec, Can
Fondé
-
Sunshine Biopharma Inc est coté dans le secteur Coml Physical, Biologcl Resh de la NASDAQ avec le ticker SBFM. Le dernier cours de clôture d'Sunshine Biopharma était de US$2,87. Au cours de la dernière année, les actions de Sunshine Biopharma ont été négociées dans une fourchette de prix de US$ 2,1056 à US$ 571,20.

Sunshine Biopharma compte actuellement 1 999 660 actions en circulation. La capitalisation boursière d'Sunshine Biopharma est de US$5,74 million. Sunshine Biopharma a un ratio cours/bénéfice (ratio PE) de -1.27.

SBFM Dernières nouvelles

Plus de nouvelles

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

20 Août 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 Août 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

16 Août 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

14 Août 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Août 2024
Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements

11 Juillet 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 Mars 2024
Edgar (US Regulatory)

Form PRE 14C - Other preliminary information statements

05 Mars 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Mars 2024
Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

23 Février 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.02-0.6920415224912.892.9682.82567442.89136673CS
4-0.15-4.966887417223.023.592.761413973.06755181CS
120.062.135231316732.813.592.10567697372.56974458CS
26-3.228-52.9353886526.0986.182.10565238732.95262174CS
52-477.13-99.4020833333480571.22.10567333775139.29426334CS
156-5497.13-99.94781818185500197402.105637708753122.62049137CS
260-5497.13-99.94781818185500197402.105637708753122.62049137CS

SBFM - Frequently Asked Questions (FAQ)

What is the current Sunshine Biopharma share price?
The current share price of Sunshine Biopharma is US$ 2,87
How many Sunshine Biopharma shares are in issue?
Sunshine Biopharma has 1 999 660 shares in issue
What is the market cap of Sunshine Biopharma?
The market capitalisation of Sunshine Biopharma is USD 5,74M
What is the 1 year trading range for Sunshine Biopharma share price?
Sunshine Biopharma has traded in the range of US$ 2,1056 to US$ 571,20 during the past year
What is the PE ratio of Sunshine Biopharma?
The price to earnings ratio of Sunshine Biopharma is -1,27
What is the cash to sales ratio of Sunshine Biopharma?
The cash to sales ratio of Sunshine Biopharma is 0,24
What is the reporting currency for Sunshine Biopharma?
Sunshine Biopharma reports financial results in USD
What is the latest annual turnover for Sunshine Biopharma?
The latest annual turnover of Sunshine Biopharma is USD 24,09M
What is the latest annual profit for Sunshine Biopharma?
The latest annual profit of Sunshine Biopharma is USD -4,51M
What is the registered address of Sunshine Biopharma?
The registered address for Sunshine Biopharma is 6500 TRANS-CANADA HIGHWAY 4TH FLOOR, POINTE-CLAIRE, QUEBEC, MONTREAL, QUEBEC, H9R 0A5
What is the Sunshine Biopharma website address?
The website address for Sunshine Biopharma is www.sunshinebiopharma.com
Which industry sector does Sunshine Biopharma operate in?
Sunshine Biopharma operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
HWHHWH International Inc
US$ 0,51
(77,27%)
5,77M
TVGNTevogen Bio Holdings Inc
US$ 2,18
(61,48%)
5,9M
WMPNWilliam Penn Bancorporation
US$ 19,66
(58,55%)
2
LENZLENZ Therapeutics Inc
US$ 35,99
(46,60%)
1
ACTUActuate Therapeutics Inc
US$ 13,99
(38,38%)
1
DSGNDesign Therapeutics Inc
US$ 2,00
(-59,76%)
4
FRAFFranklin Financial Services Corporation
US$ 22,00
(-34,01%)
202
FNLCFirst Bancorp Inc
US$ 17,00
(-32,57%)
203
ACONAclarion Inc
US$ 0,0395
(-28,05%)
2,86M
ANNAAleAnna Inc
US$ 9,00
(-25,00%)
200
TVGNTevogen Bio Holdings Inc
US$ 2,18
(61,48%)
5,9M
HWHHWH International Inc
US$ 0,51
(77,27%)
5,77M
NVDANVIDIA Corporation
US$ 132,10
(-7,38%)
3,09M
ACONAclarion Inc
US$ 0,0395
(-28,05%)
2,86M
ASSTAsset Entities Inc
US$ 1,37
(22,32%)
1,76M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SBFM
Sunshine Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés